MetaVia
MTVA | NASDAQ
$1.21
-$0.09 (-6.92%)
At close: Nov 16, 2026, 4:00 PM ET
$1.29
+$0.08 (+6.61%)
After-hours:
Nov 16, 2026, 7:48 PM ET
-6.92%
(1D)No price chart data available for 1D timeframe.
Rating
35.2
Fundamentals Weak
Market Sentiment Neutral
Moat None
Sector Rank #652/1021 (Top 64%)
Key Statistics
Market Data
Market Cap $7.94M
1D Range
1.18 1.30
52W Range
0.97 11.52
Valuation (TTM)
PE -0.38
PB 3.29
EV/EBITDA 0.04
Valuation (NTM)
Forward PE N/A
Forward PEG 0.01
Price Target $20.00
Cash Flow
FCF Yield -209.3%
SBC Adj. FCF Yield -214.8%
SBC Impact -2.6%
Margins
Gross Margin 0.0%
Operating Margin 0.0%
FCF Margin N/A
Growth (CAGR)
Revenue 3Y | 5Y N/A |
N/A
Dil EPS 3Y | 5Y 104.6% |
93.5%
FCF 3Y | 5Y 16.4% |
-9.4%
Returns
ROA -164.3%
ROE -265.5%
ROIC -628.1%
Financial Health
Net Cash
$8.62M
Current Ratio 1.32
Interest Coverage 0.00
Dividends
Div Yield N/A
Payout Ratio N/A
FCF Payout Ratio N/A
Loading financial charts...
Profile
Headquartered in Cambridge, Massachusetts, MetaVia Inc. operates as a clinical-stage biotechnology company with a core focus on discovering and commercializing novel pharmaceutical solutions for cardi...
Sector Healthcare
Industry Biotechnology
Employees 8
IPO Date Aug 5, 2016
Website www.metaviatx.com
Fiscal Year January - December
Latest News
No news articles available yet.
Analyst Summary
# of Analysts
1
Consensus
Buy
Price Target
$20.00
Upside
+1552.89%
Buy (1)
Hold (0)
Sell (0)
Add to Watchlist
Select watchlists to add or remove MTVA